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Human dipeptidyl peptidase 4 (hDPP4) was recently identified as the receptor for Middle East respiratory syndrome coronavirus
(MERS-CoV) infection, suggesting that other mammalian DPP4 orthologs may also support infection. We demonstrate that
mouse DPP4 cannot support MERS-CoV infection. However, employing mouse DPP4 as a scaffold, we identified two critical
amino acids (A288L and T330R) that regulate species specificity in the mouse. This knowledge can support the rational design of
a mouse-adaptedMERS-CoV for rapid assessment of therapeutics.
Middle East respiratory syndrome coronavirus (MERS-CoV)is a recently identified betacoronavirus that can infect the
lower respiratory airway of humans, leading to acute respiratory
distress syndrome (ARDS) with 43% mortality in hospitalized
individuals (1). Disease symptoms associated with MERS-CoV
are similar to those of severe acute respiratory syndrome corona-
virus (SARS-CoV); however, MERS-CoV is phylogenetically
more closely related to the bat coronavirusesHKU4 andHKU5 (2,
3). MERS-CoV also differs from SARS-CoV in terms of receptor
usage, whereMERS-CoVutilizes dipeptidyl peptidase 4 (DPP4) as
an entry receptor (4). Given the importance of MERS-CoV as an
emerging pathogen, there is a clear need for the development of
new therapeutics, which requires the appropriate animal models.
However, to date, nonhuman primates are the only reported ani-
mal model forMERS-CoV replication, while traditional small an-
imal models, such as ferrets (5), hamsters (6), and mice (7), are
nonpermissive. Given that species-specific differences in DPP4
may confound animal model development, it is important to
identify determinants in DPP4 that govern MERS-CoV host
range. Knowledge of DPP4 determinants may provide novel in-
sights into interactions between DPP4 and MERS-CoV spike re-
ceptor binding domain (RBD), as well as support development of
new small animal models.
To test whether mouse DPP4 (mDPP4) is capable of acting as
an entry receptor for MERS-CoV, we compared mDPP4 with hu-
manDPP4 (hDPP4). An ectopic expression systemwas utilized to
constitutively express mDPP4 and hDPP4 in human embryonic
kidney 293T (HEK 293T) cells, which lack detectable expression
of endogenous hDPP4 (data not shown). Human DPP4 and
mouse DPP4 were expressed either as full-length proteins or as
fusions to the Venus protein at the carboxy terminus. HEK 293T
cells were transfected with 3 g of the indicated DPP4 expression
plasmid, and at 20 h posttransfection, cells were infected at a
multiplicity of infection (MOI) of 5 with a recombinant MERS-
CoV strain designed to express tomato red fluorescent protein
(rMERS-CoV-red) (Fig. 1). The rMERS-CoV-red virus is derived
from the EMC2012 substrain and was previously shown to infect
and replicate in a manner similar to wild-type MERS virus (8).
Transfection of the DPP4-Venus fusion constructs resulted in
high transfection efficiency (nearly 100%) (Fig. 1A and B). Con-
trol HEK 293T cells were poorly permissive forMERS-CoV, while
cells overexpressing hDPP4 were readily infected with rMERS-
CoV-red virus (Fig. 1A), whereas mDPP4 overexpression did not
support infection (Fig. 1B). Notably, the Venus protein does not
interfere with the capacity of hDPP4 to allow viral infection (Fig.
1A and B). Despite the inability of mDPP4 to confer infection of
rMERS-CoV-red, we could readily detect expression of the
mDPP4 protein in 293T cells (Fig. 1C). Moreover, MERS-CoV S
and N proteins were detected in cells expressing hDPP4 but not
mDPP4 (Fig. 1D). These results indicate that the mDPP4 protein
cannot support MERS-CoV infection, whereas hDPP4 readily
promotes infection, as demonstrated previously (4).
The recently published crystal structures of the MERS spike
protein interacting with hDPP4 revealed a number of specific
amino acids in blades IV and V of the -propeller domain from
hDPP4 that may facilitate an interaction with the spike protein
receptor binding domain (RBD) (9, 10). Alignment of hDPP4 and
mDPP4 sequences in this region exhibits amino acid variation
thatmay account for differences inMERS-CoV susceptibility (Fig.
2A). We interrogated this region for the potential to confer infec-
tion onto mouse DPP4 using overlap extension PCR to replace
amino acids 273 to 340 in mDPP4 with amino acids 279 to 346 of
human DPP4 (Fig. 2A). Mouse DPP4 proteins bearing human
DPP4 amino acids are referred to as “chimeric DPP4” (chDPP4)
molecules, with the amino acid numbers relative to mDPP4 fol-
lowing in parentheses. Cells expressing chDPP4(273–340) were as
susceptible to rMERS-CoV-red infection as cells expressing wild-
type hDPP4 (Fig. 2B). These results clearly indicate that the
hDPP4 region comprising amino acids 279 to 346 confers to
mDPP4 the ability to support infection. In an effort to understand
if mDPP4 is structurally distinct from hDPP4 in this region, we
employed three-dimensional (3D) molecular visualization using
PyMOL software. Overlaying mDPP4 on hDPP4 shows that the
two proteins are highly similar in structure (Fig. 2C). This is espe-
cially important at the interface with the MERS spike RBD, where
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structural differences are anticipated based on distinct differences
in susceptibility to MERS infection.
In the absence of obvious structural differences, we hypothe-
sized that specific amino acids contribute to infection of cells that
overexpress chDPP4(273–340). To confirm this, we initially mu-
tated five functionally variant surface amino acids in this region of
mDPP4 to the corresponding amino acid fromhDPP4using over-
lap extension PCR to generate various chDPP4 molecules (Fig.
3A). HEK 293T cells were transfected with the indicated chDPP4
constructs followed by infection with rMERS-CoV-red at anMOI
of 1. A chDPP4 molecule containing all five mutations (P282T
A288L R289I T330R V340I)—shown as “chDPP4 (5 mutations)”
in Fig. 3—promoted highly efficient MERS-CoV infection
(Fig. 3B), indicating that one or more of these mutations may be
sufficient for infection. Previous structural studies of hDPP4 and
the MERS RBD suggest that the interaction may require at least
two distinct interactions localized to separate structural domains
(10). Our T330R and V340I mutants are localized at or near one
domain, while mutations comprising P282T, A288L, and R289I
are located in the second domain. Accordingly, each group of
mutations (T330R V340I and P282T A288L R289I) was indepen-
dently introduced into mDPP4 and tested for its capacity to sup-
port infection of rMERS-CoV-red (Fig. 3B). Although both
groups of mutations influence infection to different degrees, nei-
ther set recapitulated the levels of infection seen with all five mu-
tations together (Fig. 3B). Further dissection of each group into
FIG 1 Mouse DPP4 (mDPP4) does not support MERS-CoV infection. HEK 293T cells were transfected with 3g of plasmid expressing humanDPP4 (hDPP4)
or hDPP4-Venus fusion (A) and mDPP4 or mDPP4-venus fusion (B). At20 h posttransfection, cells were infected with rMERS-CoV-red virus at an MOI of
5. Venus fusion proteins were assessed by fluorescence microscopy at 48 h posttransfection. In independent experiments, infection with rMERS-CoV-red virus
was assessed for red cells by fluorescence microscopy at 18 h postinfection. (C) Western blot analysis demonstrates overexpression of mDPP4 and hDPP4.
Extracts were prepared at48 h posttransfection usingAV lysis buffer (3), and samples were heat inactivated for 60min at 90°C for removal from a biosafety level
3 (BSL3) facility and resolved on an 8% SDS-PAGE gel. Blots were probed with primary goat-anti-DPP4 polyclonal antibody (R&D Systems) at 1:1,000 in 1
Tris-buffered saline–Tween (TBST) or goat anti-actin polyclonal antibody (Santa Cruz) and detected with a secondary rabbit anti-goat–horseradish peroxidase
(HRP)-conjugated antibody (Sigma) at 1:10,000 in 1TBST in 5%milk. (D)Western blot analysis ofMERS-CoVS andNproteins. Lysateswere collected at18
h postinfection and treated as in panel C. Blots were probedwith primarymouse polyclonal antiserum at 1:400, raised to S andNproteins as described previously
(3), and detected with a secondary goat anti-mouse–HRP (GE Healthcare) at 1:10,000 in 1 TBST in 5% milk.
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single mutants revealed that A288L and T330R were partly re-
sponsible for the observed infection from each respective group
(Fig. 3B). These results are substantiated byWestern blot analysis
demonstrating detection of theN protein in infected cells express-
ing either theA288L orT330Rmutation but not in cells expressing
chDPP4s with the P282T, R289I, or T330R mutation (Fig. 3D).
Combination of these twomutations (chDPP4 A288L T330R) re-
capitulates the level of infection observed for chDPP4 containing
all five mutations and approaches what is observed with hDPP4
(Fig. 3B). Quantitation of MERS-CoV-infected red cells (Fig. 3C)
and Western blotting of infected cells (Fig. 3D) substantiate the
permissibility of chDPP4 A288L T330R, exhibiting nearly a 1.5-
log increase in infection compared to mDPP4 (Fig. 3C). Never-
theless, themutants did not achieve the level of infection observed
with hDPP4, indicating that additional amino acids that differ
between mice and humans may also contribute to MERS-CoV
infection. Regardless of the DPP4 mutation examined, all were
efficiently expressed, and intriguingly, all chDPP4 mutants with
the T330R mutation exhibit a shift from a doublet to a single
lower-molecular-weight band, potentially indicating glycosyla-
tion at this site (Fig. 3D). Additionally, the possibility of a restric-
tion factor in rodent cells could be eliminated since mouse and
hamster cells ectopically expressing the indicatedDPP4swere per-
missive to MERS-CoV-red infection, with the exception that
mDPP4 does not support infection, as observed with HEK 293T
cells (Fig. 4). Our results indicate that a successful infection re-
quires a combination of at least two mutations (A288L and
T330R), located at distinct structural domains on blades IV and V
of the -propeller of DPP4. These results are in agreement with
previous crystal structure data from hDPP4 and the spike RBD,
which suggest the hDPP4 equivalents (L294 and R336) are critical
residues for binding and infection (9, 10). Our structure predic-
tion model (Fig. 2B) indicates that A288 and L294 and T330 and
R336 exhibit positional differences that may govern distinct func-
tional interactions with the MERS-CoV spike protein RBD. Pre-
vious phylogenetic analyses indicate that mouse, bat, and ferret
FIG2 Blades IV andV from the-propeller of hDPP4makemDPP4 permissible toMERS-CoV infection. (A)VectorNTI protein sequence alignment of human
(top strand) andmouse (bottom strand) DPP4molecules. Yellow highlighted regions indicate conserved amino acids, white regions signify amino acids that are
functionally different (i.e., hydrophobic and hydrophilic), and green highlighting indicates amino acids that are different but functionally similar (i.e., the
threonine and serine are both polar and uncharged). (B)HEK 293T cells were transfected with the indicatedDPP4. At20 h posttransfection, cells were infected
with rMERS-CoV-red virus at anMOI of 5, and infection was assessed18 h postinfection by fluorescencemicroscopy. (C) 3Dmolecular PyMOL software was
employed to visualize the mDPP4 structure overlaid onto the hDPP4 structure. The hDPP4 structure was based upon the crystal structure resolved in context
with the MERS S RBD (PDB code 4L72). MERS S protein is displayed in red, hDPP4 in yellow, and mDPP4 in blue. The mDPP4 sequence was threaded using
the I-TASSER software (11). The expanded view depicts the DPP4 region at the interaction surface. Numbered and highlighted are the specific amino acids
chosen for mutation in the mDPP4 protein.
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FIG 3 MERS-CoV infection is dependent upon specific amino acids in DPP4. (A) Vector NTI protein sequence alignment of hDPP4 (top strand) with chDPP4
(middle strand) andmDPP4 (bottom strand) indicating positions of introduced humanmutationswith red arrows. (B)HEK 293T cells were transfectedwith the
indicatedDPP4molecule. At20 h posttransfection, cells were infected with rMERS-CoV-red virus atMOI of 1, and infection was assessed18 h postinfection
by fluorescence microscopy. (C) In an independent experiment, cells overexpressing the indicated DPP4 constructs were infected with rMERS-CoV-red virus at
MOI of 0.1, 0.01, and 0.001 on six-well plates. At18 h postinfection, cells were scored at the followingMOI: no DPP4 andmDPP4, 0.1; chDPP4 P282T A288L
R289I T330R V340I [“chDPP4 (5 mutations)”] and chDPP4 A288L T330R, 0.01; and hDPP4, 0.001. Values were normalized to anMOI of 0.1 and expressed as
relative infection at 0.1. Human DPP4, chDPP4 P282T A288L R289I T330R V340I, and chDPP4 A288L T330R showed a significant increase in infection over
mDPP4 (*, P 0.05, Student’s t test). (D) Western blots demonstrating overexpression of hDPP4, mDPP4, and each chDPP4 molecule, N protein of infected
cells, and -actin as a loading control. Western blots were prepared and probed as described in Fig. 1C and D.
FIG 4 Human and chimeric DPP4 molecules can support MERS-CoV infection in hamster and mouse cells. (A) Baby hamster kidney 21 (BHK-21) cells were
electroporated with the indicated DPP4molecules. At20 h posttransfection, cells were seeded in 6-well plates and infected with rMERS-CoV-red at anMOI of
2 at 24 h posttransfection. (B) Mouse NIH 3T3 cells were transfected using Nucleofection (according to the Amaxa procedure) with the indicated DPP4
molecules. Cells were seeded into 12-well plates and infected with rMERS-CoV-red at an MOI of4 at 24 h post-Nucleofection. All infections were assessed at
24 h postinfection by fluorescence microscopy.
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DPP4s are highly divergent fromprimateDPP4s (4, 5), despite the
capacity of bat DPP4 to serve as a functional receptor for MERS-
CoV infection (4). Moreover, swapping the hDPP4 region con-
taining blades IV and V of the -propeller into the ferret DPP4
resulted in a gain of infection, although the exact residues that
mediate this function were not identified (5). Taken together,
these data indicate that DPP4 proteins may be structurally con-
served across mammalian species. Incorporation of the A288L
and T330R modifications in the context of the mDPP4 will facil-
itate generation of a mouse model through the production of
transgenics and can be used to adapt the MERS-CoV to use
mDPP4.
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